| 產品詳情 |
| Edit |   |
|---|
| Product Name | MK-0941 |
|---|
| Description | MK-0941 is selective, allosteric glucokinase activator (GKA) that activates glucokinase (hexokinase subtype IV) with greater selectivity than over different hexokinase isoforms. MK-0941 shows decrease in mean fasting plasma glucose in healthy participants by 30 mg/dL. It displays greater effect in type 2 diabetic patients by lowering the fasting plasma glucose by 100 mg/dL. MW: 460.5. Purity ≥98% by HPLC |
|---|
| Size | 5 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 3-(6-ethanesulfonylpyridin-3-yloxy)-5-((S)-2-hydroxy-1-methylethoxy)-N-(1-methyl-1H-pyrazol-3-yl)benzamide |
|---|
| Gene, Accession, CAS # | CAS: 1137916-97-2 |
|---|
| Catalog # | B1207-5 |
|---|
| Price | |
|---|
| Order / More Info | MK-0941 from BIOVISION, INC. |
|---|
| Product Specific References | n/a |
|---|
| 產品資料 |
|
|